Subscribe To
Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch
One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up of the ET5, the EV maker's newest model unve...
January 31, 2022, 12:07 pm
Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch
One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up of the ET5, the EV maker's newest model unve...
January 31, 2022, 12:07 pm
F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers
The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned ...
January 27, 2022, 7:29 am
F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers
The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned ...
January 27, 2022, 7:29 am
F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers
The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned ...
January 27, 2022, 7:29 am
Cobalt blue attends landmark talks with korean president to discuss ethical supply of cobalt
Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) has received strong validation of its strategy to supply ...
December 14, 2021, 11:37 pm
Cobalt blue attends landmark talks with korean president to discuss ethical supply of cobalt
Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) has received strong validation of its strategy to supply ...
December 14, 2021, 11:37 pm
Cobalt blue attends landmark talks with korean president to discuss ethical supply of cobalt
Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) has received strong validation of its strategy to supply ...
December 14, 2021, 11:37 pm
Gbs shares are rallying on plans for covid-19 antibody trials after validation study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion o...
November 30, 2021, 1:11 pm
Gbs shares are rallying on plans for covid-19 antibody trials after validation study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion o...
November 30, 2021, 1:11 pm
Gbs shares are rallying on plans for covid-19 antibody trials after validation study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion o...
November 30, 2021, 1:11 pm
Sesen bio: hoping for an easy revalidation of vicineum by 2022
The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...
November 16, 2021, 9:11 pm
Sesen bio: hoping for an easy revalidation of vicineum by 2022
The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...
November 16, 2021, 9:11 pm
Sesen bio: hoping for an easy revalidation of vicineum by 2022
The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...
November 16, 2021, 9:11 pm
Davita climate action goals approved by the science based target initiative
DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation...
October 11, 2021, 6:02 am
Davita climate action goals approved by the science based target initiative
DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation...
October 11, 2021, 6:02 am
Davita climate action goals approved by the science based target initiative
DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation...
October 11, 2021, 6:02 am
Todos medical unveils positive clinical validation data for its 3cl protease biomarker assay tollotest in a clinical study of covid-19 patients
Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay...
October 6, 2021, 11:26 am
Todos medical unveils positive clinical validation data for its 3cl protease biomarker assay tollotest in a clinical study of covid-19 patients
Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay...
October 6, 2021, 11:26 am
Todos medical unveils positive clinical validation data for its 3cl protease biomarker assay tollotest in a clinical study of covid-19 patients
Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay...
October 6, 2021, 11:26 am